Azilsartan as "Add-On" Treatment with Methotrexate Improves the Disease Activity of Rheumatoid Arthritis.
Conclusions: Azilsartan improved the effects of methotrexate on the clinical scores and certain inflammatory biomarkers of patients with active RA. Trial Registration: The protocol was registered under the number 507/SA/1024 at the local clinical studies database, College of Medicine, Sulaimani University. PMID: 29888275 [PubMed - in process]
A woman with cystic fibrosis and lung transplants suffered chronic pain for three years after she had a tattoo on her thighGetting a tattoo if you have a weakened immune system could put you at risk of complications, doctors have warned. The caution comes after a woman with cystic fibrosis and lung transplants developed thigh and knee pain after having body art inked on her leg.Doctors say those taking immunosuppressant drugs should take precautions if considering body art. These medicines are often given after an organ transplant or to treat autoimmune conditions such as Crohn ’s disease, lupus or rheumatoid arthrit...
Conclusions: C1 lateral mass and C1-C2 transarticular polyaxial screw rod fixation techniques were effective in achieving immediate rigid immobilization of the C1-C2 motion segment. PMID: 29888028 [PubMed]
ARTHRITIS pain can be debilitating with symptoms such as inflammation in and around your joints affecting how you go about your day-to-day life. Rheumatoid arthritis is one of the most common types of arthritis, which can affect the knee, hip and hands, and having a family history of the condition can be a risk factor. But there are some things you can change in your lifestyle to reduce the risk, delay onset or altogether prevent arthritis.
(Wiley) Drugs used to treat rheumatoid arthritis may impact mental health by improving pain and stiffness and by targeting inflammatory processes common to arthritis and depression; however, a recent review of published studies demonstrates that relying on rheumatoid arthritis therapies alone may not meaningfully improve patients' mental health.
CONCLUSIONS: The findings of this systematic review suggest that self-efficacy might have a positive effect on the prognosis of this condition, although further longitudinal studies are needed. PMID: 29873569 [PubMed - as supplied by publisher]
ARTHRITIS pain affects about 10 million people in the UK. Arthritis symptoms include joint pain and inflammation in the knees, hands or feet. But, adding this fish dinner to your diet could reduce signs of rheumatoid arthritis or osteoarthritis.
AbstractDiclofenac is widely used to manage chronic inflammatory and degenerative joint diseases such as osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, and extra-articular rheumatism. Its various mechanisms of action make it particularly effective in treating nociceptive pain, but it is also an alternative for treating spinal and chronic central pain. Osteoarthritis and rheumatoid arthritis are the most frequently encountered arthritic conditions in adults. The management of nociceptive pain requires a sequential hierarchical approach, with the initial NSAID treatment being characterized by the rep...
ConclusionWe conclude that ocular manifestations, however rare they are, should be foreseen, investigated, and treated in patients with suspected arthritis as the complication is grave and sight threatening.
ARTHRITIS pain is one of the symptoms of the condition. Other signs include joint stiffness, swelling and redness. Treatment involves medication and recommendations to exercise. You could also reduce your arthritis pain by using stinging nettles.
AbstractTo compare disease burden and biologic use among psoriatic arthritis (PsA) or rheumatoid arthritis (RA) patients recruited to the Corrona registry. Retrospective study of patients with PsA or RA enrolled in Corrona between January 2002 and March 2013 and grouped in 2-year intervals. Clinical outcomes and biologic use were assessed. Biologic use increased over time in both cohorts, with 62 and 52% of patients with PsA and RA, respectively, receiving biologics by 2012 –2013. However, 25 and 35% of patients with PsA and RA, respectively, continued to experience moderate/high disease activity. Overall, the progre...